Inicio › Linfoma › Ohio › Cleveland
Ensayos clínicos de Linfoma en Cleveland, OH
13 estudios para Linfoma buscan participantes en centros de Cleveland y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
ReclutandoFase 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
ReclutandoFase 2
- University Hospitals Cleveland Medical Center, Cleveland
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
ReclutandoFase 2
- Cleveland Clinic, Cleveland
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ReclutandoFase 2
- The Cleveland Clinic Foundation, Cleveland
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
ReclutandoFase 3
- Research Site, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- Cleveland Clinic, Cleveland
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
ReclutandoFase 1/2
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutandoFase 3
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
ReclutandoFase 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Cleveland Clinic, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Cleveland Clinic, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
ReclutandoFase 1
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Más información sobre Linfoma en MedlinePlus
Ensayos de Linfoma en otras ciudades
- Houston, TX34 estudios
- New York City, NY33 estudios
- Boston, MA33 estudios
- Washington, DC23 estudios
- Baldwin Park, CA21 estudios
- Chicago, IL20 estudios
- Durham, NC17 estudios
- St. Louis, MO15 estudios
- Philadelphia, PA15 estudios
- Edison, NJ12 estudios
- Seattle, WA12 estudios
- Atlanta, GA11 estudios
Otros estudios en Cleveland
- Cáncer de pulmón de células no pequeñas43 estudios
- Cáncer (todos los tipos)36 estudios
- Cáncer de seno35 estudios
- Cáncer de próstata34 estudios
- Fallo cardíaco33 estudios
- Cáncer metastásico30 estudios
- Cáncer de ovario28 estudios
- Cáncer de pulmón26 estudios
- Cáncer del colon y del recto24 estudios
- Enfermedad cardiovascular22 estudios
- Cáncer de endometrio21 estudios
- Leucemia mielógena aguda20 estudios
De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.